HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salicylideneamino-2-thiophenol enhances osteogenic differentiation through the activation of MAPK pathways in multipotent bone marrow stem cell.

Abstract
Osteoporosis is a reduction in skeletal mass due to an imbalance between bone formation and bone resorption. Therefore, the identification of specific stimulators of bone formation is of therapeutic significance in the treatment of osteoporosis. Salicylideneamino-2-thiophenol (Sal-2) consists of two benzene rings, has been reported to possess antioxidant activity, and is an effective remedy for fever and rheumatic diseases. However, until now the effects of osteoblastic bone formation by Sal-2 were unknown. In this study, we investigated the effects of Sal-2 on osteogenic differentiation of multipotent bone marrow stromal stem cells by alizarin red S staining for osteogenic differentiation, RT-PCR and western blot for alkaline phosphatase (ALP) activity and signaling pathways, FACS analysis and immunofluorescence staining for CD44 and CD51 expression, calcium assays, and immunofluorescence staining for signaling pathways. We found that Sal-2 enhanced the osteogenic differentiation of multipotent bone marrow stromal stem cells. Sal-2 treatment induced the expression and activity of ALP, and enhanced the levels of CD44 and CD51 expression as well as Ca2+ content, in multipotent bone marrow stromal stem cells. Moreover, we found that Sal-2-induced osteogenic differentiation and expression of osteogenesis-related molecules involve the activation of the MAPK and nuclear factor-κB pathways. Our findings provide insight into both the mechanism and effects of Sal-2 on osteogenic differentiation and demonstrate that Sal-2 may be a beneficial adjuvant in stimulating bone formation in osteoporotic diseases.
AuthorsHyung Keun Kim, Kyung Soon Park, Jun Sik Lee, Ji Hyun Kim, Dae Sung Park, Jung-Woog Shin, Taek Rim Yoon
JournalJournal of cellular biochemistry (J Cell Biochem) Vol. 113 Issue 6 Pg. 1833-41 (Jun 2012) ISSN: 1097-4644 [Electronic] United States
PMID22228489 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Wiley Periodicals, Inc.
Chemical References
  • Hyaluronan Receptors
  • Integrin alphaV
  • NF-kappa B
  • Salicylates
  • Sulfhydryl Compounds
  • salicylideneamino-2-thiophenol
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Alkaline Phosphatase
  • Calcium
Topics
  • Alkaline Phosphatase (biosynthesis, metabolism)
  • Bone Marrow Cells (drug effects, metabolism)
  • Calcium (analysis)
  • Cell Differentiation (drug effects, physiology)
  • Cell Line
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Humans
  • Hyaluronan Receptors (biosynthesis)
  • Integrin alphaV (biosynthesis)
  • MAP Kinase Signaling System (drug effects)
  • Multipotent Stem Cells (drug effects, metabolism)
  • NF-kappa B (metabolism)
  • Osteogenesis (drug effects)
  • Salicylates (pharmacology)
  • Sulfhydryl Compounds (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: